|
SANOFI-AVENTIS’S ACOMPLIA TO HAVE HUGE IMPACT
ON THE OBESITY DRUG MARKET
Lack of Reimbursement Weighs Down the Market, According
to a New Study from Decision Resources Waltham,
Mass.--September 1, 2004--Decision Resources, Inc., one of
the world’s leading research and advisory firms focusing
on pharmaceutical and health care issues, finds that Sanofi-Aventis’s
Acomplia, a novel cannabinoid CB1 receptor antagonist, will
have a huge impact on the obesity drug market. According to
a new Pharmacor study entitled Obesity, the market
will reach $2.3 billion in 2013 primarily driven by the strength
of Acomplia's sales. Set to launch in 2006, Acomplia is poised
to become the first antiobesity agent to achieve blockbuster
status.
The study also finds that lack of reimbursement for
weigh-loss therapies results in out-of-pocket expenses of
approximately $3 per day for two leading antiobesity agents:
orlistat (Roche’s Xenical) and sibutramine (Abbott’s
Meridia and AstraZeneca’s Reductil).”
“The high cost of these therapies is the top reason
for noncompliance and discontinuation of drug therapy,”
said Donny Wong, Ph.D., analyst at Decision Resources. “According
to physicians that we interviewed, many patients cannot afford
to refill their prescriptions. Therefore, a significant commercial
opportunity exists for agents that can offer safety and efficacy
profiles similar to those of orlistat and sibutramine, but
at a reduced cost.”
About Obesity
Metabolic syndrome is a constellation of metabolic
abnormalities that are associated with increased risk for
cardiovascular disease. These metabolic abnormalities include
glucose intolerance, insulin resistance, obesity, type 2 diabetes,
dyslipidemia, and hypertension.
About Pharmacor from Decision Resources
Pharmacor is a unique family of studies that assesses a host
of market-impacting factors and analyzes the commercial outlook
for drugs in research and development.
About Decision Resources
Decision Resources, Inc., (www.decisionresources.com)
is a world leader in research publications, advisory services,
and consulting designed to help clients shape strategy, allocate
resources, and master their chosen markets.
###
For more information, contact:
Elizabeth Marshall
Decision Resources, Inc.
781.296.2563
< BACK
|
